Mounjaro & Weight Management
Medically supervised weight-loss programs using the latest treatments.
About this specialty
Integrated, medically supervised weight-management programs including Mounjaro (tirzepatide) injections, personalized nutrition plans and regular follow-up for safe, sustainable weight loss.
Our services in this specialty
Related articles
GeneralOzempic Injections: Benefits, Dosage, Side Effects & Weight Loss Results
Ozempic injections have become widely known as a prescription treatment containing semaglutide, a medication from the GLP-1 receptor agonist class. Ozempic is primarily used alongside diet and physical activity to improve blood sugar control in adults with type 2 diabetes. It also has approved cardiovascular and kidney-related benefits for specific groups of patients. According to the World Health Organization (WHO), approximately 2.5 billion adults worldwide were overweight in 2022, including more than 890 million people living with obesity.
Read more
GeneralWegovy: Benefits, Dosage, Weight Loss Results & How It Works
Wegovy has become one of the well-known prescription medications used as part of comprehensive weight management for people living with obesity or overweight with weight-related health conditions. It contains semaglutide, a GLP-1 receptor agonist (Glucagon-Like Peptide-1) that helps regulate appetite, increase feelings of fullness, and support long-term weight management when combined with a reduced-calorie diet and regular physical activity. According to the World Health Organization (WHO), around 2.5 billion adults worldwide were overweight in 2022, including more than 890 million adults living with obesity. Obesity is considered a chronic and complex disease that requires long-term management.
Read more
GeneralWeight Loss: Effective Ways to Lose Weight and Manage Obesity
Weight loss and healthy weight management have become important aspects of modern healthcare, particularly as overweight and obesity continue to affect populations worldwide. The World Health Organization (WHO) classifies obesity as a chronic, relapsing disease influenced by complex interactions between genetics, biology, eating behaviors, physical activity, and the surrounding environment. In 2022, approximately 2.5 billion adults worldwide were overweight, including around 890 million adults living with obesity. WHO also reported that approximately 16% of adults globally were living with obesity that year.
Read more